Submitted by Anonymous (not verified) on 7 May 2026 - 15:12
Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation: 08/09/2003, Revision: 97, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation: 08/09/2003, Revision: 97, Status: Authorised